ELV | Elevance health inc - Stock Value & PE Ratio Analysis

3

24

15

Limited Growth

AI analysis rates ELV with a lower value score of 2.
It is mainly due to potential higher debt, along with potential value may be lower.
Over the past 3 months, ELV has maintained a consecutive value rating of 2.0, slightly lower than the rating of 2.9 over the past 3 years, indicating slight decrease in enterprise value.
Compared to all stocks in the Health Care sector, ELV has a medium value rating.

ELV Value Reference Factors

The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.

Update to 2025/04/25 (Weekly Update)

ELV Financial Forecast

Unit : USD

Update to 2025/5/4 (Quarterly Update)

ELV Earnings Table

Unit : USD

QTR	Non-GAAP EPS	EPS YoY	EPS Surprise %	Sales	Sales YoY	Sales Surprise %	NPM
Current	11.97	12.5%	4.9%	48.89B	14.8%	5.6%	0.9%
2024Q3	3.84	-31.7%	1.1%	45.44B	6.6%	1.1%	2.3%
2024Q2	8.37	-6.9%	-13.4%	45.15B	5.4%	3.9%	5.3%
2024Q1	10.12	11.9%	1.1%	43.65B	-0.1%	1.5%	5.3%
2023Q4	10.64	12.5%	1%	42.58B	1%	0.2%	2%

Update to 2025/5/7 (Quarterly Update)

ELV Historical Value Score

You can use historical scores of 3 or above to observe potential performance and make investment decisions.

ELV Value Strategy Backtest

The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.

Entry

Exit

The Backtest Result of ELV from 2007/01 till Now

313.11%
Cumulative Return: 8.06%
Annual Return: 24.23%
Volatility: 0.33
Sharpe Ratio

Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from January, 2007 to May, 2025. (Total Trades: 4)